MAPK |
1843 |
DUSP1 |
3.89 |
0.02027 |
Up |
Dual specificity phosphatase 1 |
MAPK |
2768 |
GNA12 |
3.70 |
0.02885 |
Up |
Guanine nucleotide binding protein (G protein) alpha 12 |
MAPK |
5879 |
RAC1 |
3.15 |
0.00019 |
Up |
RAS-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
MAPK |
22808 |
MRAS |
3.14 |
0.00491 |
Up |
Muscle RAS oncogene homolog |
MAPK |
2002 |
ELK1 |
2.80 |
0.01115 |
Up |
ELK1, member of ETS oncogene family |
MAPK |
5595 |
MAPK3 |
2.73 |
0.01417 |
Up |
Mitogen-activated protein kinase 3 |
MAPK |
994 |
CDC25B |
2.66 |
0.03507 |
Up |
Cell division cycle 25B |
MAPK |
468 |
ATF4 |
2.50 |
0.04995 |
Up |
Activating transcription factor 4 (tax-responsive enhancer element B67) |
MAPK |
3925 |
STMN1 |
2.47 |
0.01463 |
Up |
Stathmin 1/oncoprotein 18 |
MAPK |
4149 |
MAX |
2.31 |
0.00410 |
Up |
MYC associated factor X |
MAPK |
7048 |
TGFBR2 |
2.18 |
0.03642 |
Up |
Transforming growth factor, beta receptor II (70/80 kDa) |
MAPK |
5600 |
MAPK11 |
2.12 |
0.04901 |
Up |
Mitogen-activated protein kinase 11 |
MAPK |
784 |
CACNB3 |
2.04 |
0.03028 |
Up |
Calcium channel, voltage-dependent, beta 3 subunit |
MAPK |
2253 |
FGF8 |
3.49 |
0.03611 |
Down |
Fibroblast growth factor 8 (androgen-induced) |
MAPK |
5922 |
RASA2 |
2.83 |
0.01406 |
Down |
RAS p21 protein activator 2 |
TLR |
7187 |
TRAF3 |
2.86 |
0.03732 |
Up |
TNF receptor-associated factor 3 |
TLR |
3454 |
IFNAR1 |
2.37 |
0.01055 |
Up |
Interferon (alpha, beta, and omega) receptor 1 |
TLR |
148022 |
TICAM1 |
2.23 |
0.02105 |
Up |
Toll-like receptor adaptor molecule 1 |
TLR |
3569 |
IL6 |
2.18 |
0.01526 |
Up |
Interleukin 6 (interferon, beta 2) |
TLR |
5879 |
RAC1 |
3.15 |
0.00019 |
Up |
RAS-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
TLR |
5595 |
MAPK3 |
2.73 |
0.01417 |
Up |
Mitogen-activated protein kinase 3 |
TLR |
5600 |
MAPK11 |
2.12 |
0.04901 |
Up |
Mitogen-activated protein kinase 11 |
TLR |
3439 |
IFNA1 |
2.62 |
0.03022 |
Down |
Interferon, alpha 1 |